Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteine

This publication has 26 references indexed in Scilit:

• Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitro
  Chemico-Biological Interactions, 1982
• Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro
  Chemico-Biological Interactions, 1982
• Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation
  Chemico-Biological Interactions, 1982
• The mutagenicity of nitroaromatic drugs
  Mutation Research/Genetic Toxicology, 1980
• The effect of nitroheterocyclic drugs on DNA: An in vitro model of cytotoxicity
  Biochemical Pharmacology, 1979
• Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions
  British Journal of Cancer, 1979
• The interaction of reduced metronidazole with DNA
  Biochemical Pharmacology, 1978
• Mammalian cell toxicity of nitro compounds: Dependence upon reduction potentiakl
  Biochemical and Biophysical Research Communications, 1976
• Antitrichomonad Action, Mutagenicity, and Reduction of Metronidazole and Other Nitroimidazoles
  Antimicrobial Agents and Chemotherapy, 1976
• The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms
  Biochemical Pharmacology, 1974